Abstract 14P
Background
Classification of molecular subtypes of breast cancer is widely used in clinical decision-making, leading to different treatment responses and clinical outcomes. We classified molecular subtypes using a novel deep learning algorithm in whole-slide histopathological images (WSIs) with invasive ductal carcinoma of the breast.
Methods
We obtained 1,094 breast cancer cases with available hematoxylin and eosin-stained WSIs from the TCGA database. We applied a new deep learning algorithm for artificial neural networks (ANNs) that is completely different from the back-propagation method developed in previous studies.
Results
Our model based on the ANN algorithm had an accuracy of 67.8% for all datasets (training and testing), and the area under the receiver operating characteristic curve was 0.819 when classifying molecular subtypes of breast cancer. In approximately 30% of cases, the molecular subtype did not reflect the unique histological subtype, which lowered the accuracy. The set revealed relatively high sensitivity (70.5%) and specificity (84.4%).
Conclusions
Our approach involving this ANN model has favorable diagnostic performance for molecular classification of breast cancer based on WSIs and could provide reliable results for planning treatment strategies.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
281P - 10-year treatment outcome of prostate cancer patients with 3D conformal radiation: Experience of a single cancer institution in Iran
Presenter: Reyhane Bayani
Session: Poster Display
Resources:
Abstract
282P - Predictors of outcomes in patients with clinically lymph node-positive prostate cancer after definitive radiotherapy
Presenter: Jae-Sung Kim
Session: Poster Display
Resources:
Abstract
283P - Radiotherapy utilization rate and treatment patern of protate cancer at Cipto Mangunkusumo Central General Hospital (RSCM): What we learn from pre-pandemic era
Presenter: Riyan Apriantoni
Session: Poster Display
Resources:
Abstract
284TiP - CYCLONE 3: A phase III, randomized, double-blind, placebo-controlled study of abemaciclib in combination with abiraterone plus prednisone in men with high-risk metastatic hormone-sensitive prostate cancer
Presenter: Nobuaki Matsubara
Session: Poster Display
Resources:
Abstract
292P - Comparative characteristics of early cervical cancer diagnosis methods for Tashkent women
Presenter: Gulnoza Goyibova
Session: Poster Display
Resources:
Abstract
293P - Carboplatin in locally advanced cervical cancer treated with chemoradiation: An alternative to cisplatin
Presenter: Natalia Isabel Valdiviezo Lama
Session: Poster Display
Resources:
Abstract
294P - Concurrent chemoradiation with cisplatin every 3 weeks in locally advanced cervical cancer: A single arm phase II clinical trial
Presenter: Long Nguyen
Session: Poster Display
Resources:
Abstract
295P - A prospective study of dose escalated simultaneous integrated boost in node-positive cervical cancer
Presenter: Ritusha Mishra
Session: Poster Display
Resources:
Abstract
296P - Safety, efficacy, and immunogenicity of therapeutic vaccines for patients with high-grade cervical intraepithelial neoplasia (CIN 2/3) associated with human papillomavirus: A systematic review
Presenter: Caroline Amélia Gonçalves
Session: Poster Display
Resources:
Abstract
297P - The utilization rate of radiotherapy and chemotherapy for cervical cancer in Indonesia: Optimal versus actual, how far the gap?
Presenter: Charity Kotambunan
Session: Poster Display
Resources:
Abstract